| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ |
|---|---|---|---|---|---|---|---|---|
| Revenue | $2.0B | $1.9B | $1.8B | $1.7B | $1.4B | $1.3B | $0.4B | $0.4B |
| Cost of Revenue | — | — | — | — | — | — | — | — |
| Gross Profit | — | — | — | — | — | — | — | — |
| R&D Expense | — | — | — | — | — | — | — | — |
| SG&A Expense | — | — | — | — | — | — | — | — |
| Operating Income | $0.4B | $0.3B | $0.3B | $0.2B | $0.2B | $0.2B | $0.1B | $0.1B |
| Net Income | $0.2B | $0.2B | $0.2B | $0.2B | $0.1B | $0.1B | $0.1B | $0.0B |
| EPS (Basic) | $2.38 | $2.29 | $2.24 | $2.13 | $2.11 | $1.91 | $2.98 | $2.08 |
| EPS (Diluted) | $2.38 | $2.29 | $2.24 | $2.12 | $2.10 | $1.90 | $0.76 | $0.70 |
| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ |
|---|---|---|---|---|---|---|---|---|
| Total Assets | $8.4B | $7.9B | $7.7B | $7.4B | $6.9B | $6.4B | $6.1B | $5.8B |
| Current Assets | $0.7B | $0.7B | $0.7B | $0.7B | $0.4B | $0.3B | $0.3B | $0.3B |
| Cash & Equivalents | $0.0B | $0.0B | $0.0B | $0.0B | $0.0B | $0.0B | $0.0B | $0.0B |
| Total Liabilities | $5.7B | $5.3B | $5.2B | $5.1B | $4.7B | $4.4B | $4.1B | $4.0B |
| Current Liabilities | $0.9B | $0.8B | $0.8B | $1.0B | $0.9B | $0.5B | $0.5B | $0.6B |
| Stockholders' Equity | $2.7B | $2.6B | $2.5B | $2.3B | $2.2B | $2.0B | $1.9B | $1.8B |
| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ |
|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | $0.5B | $0.5B | $0.4B | $0.1B | $0.3B | $0.3B | $0.4B | $0.4B |
| Investing Cash Flow | $-0.6B | $-0.5B | $-0.5B | $-0.5B | $-0.4B | $-0.4B | $-0.4B | $-0.4B |
| Capital Expenditures | $0.6B | $0.5B | $0.5B | $0.5B | $0.4B | $0.4B | $0.4B | $0.4B |
| Financing Cash Flow | $0.1B | $0.1B | $0.1B | $0.3B | $0.2B | $0.1B | $0.0B | $0.1B |